Related references
Note: Only part of the references are listed.Methylphenidate But Not Atomoxetine or Citalopram Modulates Inhibitory Control and Response Time Variability
L. Sanjay Nandam et al.
BIOLOGICAL PSYCHIATRY (2011)
Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder A Review and Meta-Analysis of the Literature
Salma R. I. Ribeiz et al.
CNS DRUGS (2010)
Effect of nicotine on saccadic eye movement latencies in non-smokers
Alison C. Bowling et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
Nadine Petrovsky et al.
NEUROPSYCHOPHARMACOLOGY (2010)
DIFFERENTIAL EFFECTS OF NICOTINE ON P50 AMPLITUDE, ITS GATING, AND THEIR NEURAL SOURCES IN LOW AND HIGH SUPPRESSORS
V. J. Knott et al.
NEUROSCIENCE (2010)
Effect of d-amphetamine on inhibition and motor planning as a function of baseline performance
Ava-Ann Allman et al.
PSYCHOPHARMACOLOGY (2010)
Meta-analysis of the acute effects of nicotine and smoking on human performance
Stephen J. Heishman et al.
PSYCHOPHARMACOLOGY (2010)
Effects of acute nicotine on brain function in healthy smokers and non-smokers: Estimation of inter-individual response heterogeneity
Ulrich Ettinger et al.
NEUROIMAGE (2009)
Eye movement dysfunction in first-degree relatives of patients with schizophrenia: A meta-analytic evaluation of candidate endophenotypes
Monica E. Calkins et al.
BRAIN AND COGNITION (2008)
A hundred years of eye movement research in psychiatry
Christoph Klein et al.
BRAIN AND COGNITION (2008)
Decomposing the neural correlates of antisaccade eye movements using event-related fMRI
Ulrich Ettinger et al.
CEREBRAL CORTEX (2008)
The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls
Ruth S. Barr et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Haloperidol differentially modulates prepulse inhibition and P50 suppression in healthy humans stratified for low and high gating levels
Philipp A. Csomor et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison
N. Rycroft et al.
PSYCHOPHARMACOLOGY (2007)
The influence of stimulus direction and eccentricity on pro- and anti-saccades in humans
Joan M. Dafoe et al.
EXPERIMENTAL BRAIN RESEARCH (2007)
G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2007)
A double-blind placebo-controlled experimental study of nicotine: II - Effects on response inhibition and executive functioning
Lynne Dawkins et al.
PSYCHOPHARMACOLOGY (2007)
Intra-subject variability in attention-deficit hyperactivity disorder
Christoph Klein et al.
BIOLOGICAL PSYCHIATRY (2006)
The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine
Nicola Rycroft et al.
PSYCHOPHARMACOLOGY (2006)
Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia
David Potter et al.
SCHIZOPHRENIA BULLETIN (2006)
Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels
Franz X. Vollenweider et al.
BIOLOGICAL PSYCHIATRY (2006)
Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits
DV Poltavski et al.
PHYSIOLOGY & BEHAVIOR (2006)
Regulation of alpha 7-nicotinic receptor subunit and alpha 7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia
V. De Luca et al.
ACTA PSYCHIATRICA SCANDINAVICA (2006)
Nicotine reduces antisaccade errors in task impaired schizophrenic subjects
AL Larrison-Faucher et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Look away: The anti-saccade task and the voluntary control of eye movement
DP Munoz et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Effects of nicotinic stimulation on cognitive performance
PA Newhouse et al.
CURRENT OPINION IN PHARMACOLOGY (2004)
Reliability of smooth pursuit, fixation, and saccadic eye movements
U Ettinger et al.
PSYCHOPHYSIOLOGY (2003)
Nicotine and behavioral markers of risk for schizophrenia:: A double-blind, placebo-controlled, cross-over study
L Dépatie et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Where do we go from here? The importance of initial values
MA Mehta
NEUROPSYCHOPHARMACOLOGY (2002)
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
DL Braff et al.
PSYCHOPHARMACOLOGY (2001)
Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers
SJ Heishman et al.
PSYCHOPHARMACOLOGY (2000)
Effects of dextroamphetamine on cognitive performance and cortical activation
VS Mattay et al.
NEUROIMAGE (2000)
Share Paper
